S
Sea Hunter Therapeutics
Vertically integrated pharmaceutical and consumer packaged goods company
About Sea Hunter Therapeutics
Sea Hunter Therapeutics operates in the burgeoning cannabis industry, offering a comprehensive suite of services and products designed to support the growth and success of cannabis brands worldwide. The company serves a diverse range of clients, including dispensaries, cultivators, and cannabis product manufacturers. Operating primarily in North America, Sea Hunter Therapeutics leverages a portfolio of specialized companies to deliver end-to-end solutions. These include Baker, a leading CRM platform for dispensaries; Jupiter Research, known for its award-winning vaporizer technology; and Commonwealth Alternative Care, which provides medical cannabis products. The business model is vertically integrated, encompassing cultivation, production, distribution, and retail. Revenue is generated through the sale of cannabis products, technology solutions, and consulting services. The company is well-positioned in a newly regulated market, focusing on innovation and long-term success.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Cambridge, United States
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 25.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Consumer Goods, Wholesale, Intellectual Property, Retail, Biotechnology, Cannabis, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 3 companies, latest Nov 2018
- Capital deployed
- —
- Preferred round
- MERGER
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| MERGEROther financing | Nov 2018 | $0 | — | Baker Technologies · Briteside · Sante Veritas Therapeutics | — |
| GROWTH EQUITY VCOther financing | Jul 2018 | $76M | $534M | Undisclosed | — |
Growth signals
Latest recorded traffic for Sea Hunter Therapeutics is 230 monthly website visits. Sea Hunter Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Sante Veritas TherapeuticsCambridge, United StatesPharmaceuticals company based in Canada
$1.1Mvaluation
BritesideBend, United StatesConnects you to local dispensaries delivering premium cannabis to your doorstep
→
Baker TechnologiesDenver, United StatesLeading CRM for the cannabis industry, servicing more than 800 dispensaries across the US and Canada
$32Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors3 additional known investors
- Baker Technologies
- Briteside
- Sante Veritas Therapeutics
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sea Hunter Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sea Hunter Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.